The genetic basis of pachyonychia congenita

被引:78
作者
Smith, FJD
Liao, HH
Cassidy, AJ
Stewart, A
Hamill, KJ
Wood, P
Joval, I
van Steensel, MAM
Björck, E
Callif-Daley, F
Pals, G
Collins, P
Leachman, SA
Munro, CS
McLean, WHI
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Human Genet Unit, Epithelial Genet Grp, Dundee DD1 9SY, Scotland
[2] Univ Hosp Maastricht, Dept Dermatol, Maastricht, Netherlands
[3] Karolinska Hosp, Clin Genet Unit, Dept Mol Med, S-10401 Stockholm, Sweden
[4] Dept Med Genet, Dayton, OH USA
[5] Vrije Univ Amsterdam, Univ Hosp Amsterdam, Dept Clin & Human Genet, Amsterdam, Netherlands
[6] St Vincents Univ Hosp, Dept Dermatol, Dublin, Ireland
[7] Univ Utah, Dept Dermatol, Salt Lake City, UT 84112 USA
[8] So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland
基金
英国惠康基金;
关键词
genodermatosis; keratin intermediate filaments; keratoderma; mutation; nail dystrophy;
D O I
10.1111/j.1087-0024.2005.10204.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In 1994, the molecular basis of pachyonychia congenita (PC) was elucidated. Four keratin genes are associated with the major subtypes of PC: K6a or K16 defects cause PC-1; and mutations in K6b or K17 cause PC-2. Mutations in keratins, the epithelial-specific intermediate filament proteins, result in aberrant cytoskeletal networks which present clinically as a variety of epithelial fragility phenotypes. To date, mutations in 20 keratin genes are associated with human disorders. Here, we review the genetic basis of PC and report 30 new PC mutations. Of these, 25 mutations were found in PC-1 families and five mutations were identified in PC-2 kindreds. All mutations identified were heterozygous amino acid substitutions or small in-frame deletion mutations with the exception of an unusual mutation in a sporadic case of PC-1. The latter carried a 117 bp duplication resulting in a 39 amino acid insertion in the 213 domain of K6a. Also of note was mutation L388P in K17, which is the first genetic defect identified in the helix termination motif of this protein. Understanding the genetic basis of these disorders allows better counseling for patients and paves the way for therapy development.
引用
收藏
页码:21 / 30
页数:10
相关论文
共 47 条
[1]  
[Anonymous], 1993, Human gene mutation
[2]  
Basarab T, 1999, BRIT J DERMATOL, V140, P689
[3]   MUTATION OF A TYPE-II KERATIN GENE (K6A) IN PACHYONYCHIA-CONGENITA [J].
BOWDEN, PE ;
HALEY, JL ;
KANSKY, A ;
ROTHNAGEL, JA ;
JONES, DO ;
TURNER, RJ .
NATURE GENETICS, 1995, 10 (03) :363-365
[4]  
Covello SP, 1998, BRIT J DERMATOL, V139, P475
[5]   A structural scaffolding of intermediate filaments in health and disease [J].
Fuchs, E ;
Cleveland, DW .
SCIENCE, 1998, 279 (5350) :514-519
[6]   Intermediate filaments: novel assembly models and exciting new functions for nuclear lamins [J].
Herrmann, H ;
Foisner, R .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (08) :1607-1612
[7]   The intermediate filament protein consensus motif of helix 2B:: Its atomic structure and contribution to assembly [J].
Herrmann, H ;
Strelkov, SV ;
Feja, B ;
Rogers, KR ;
Brettel, M ;
Lustig, A ;
Häner, M ;
Parry, DAD ;
Steinert, PM ;
Burkhard, P ;
Aebi, U .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 298 (05) :817-832
[8]  
Hesse M, 2001, J CELL SCI, V114, P2569
[9]   Comprehensive analysis of keratin gene clusters in humans and rodents [J].
Hesse, M ;
Zimek, A ;
Weber, K ;
Magin, TM .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2004, 83 (01) :19-26
[10]   Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation [J].
Irvine, AD ;
Mclean, WHI .
BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (05) :815-828